- Research works
- 31 ▼ 56% vs 2013–17
- Citations
- 233 7.6 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Megafine Pharma (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 37.1×. Every wedge is a field page.
Which keywords describe research at Megafine Pharma (India)?
By fractional works in all years, weighted toward what it does more of than the world: Green Analytical Chemistry, Pharmaceutical Analysis, Validation, Synthesis, Chiral Separation, Liquid Chromatography, Catalysis and Endothelial Dysfunction.
- Biomineralization
- Reactive Oxygen Species
- Natural Products
- Genotoxicity
- Cardiovascular Diseases
- Biomedical Applications
- Heterocyclic Compounds
- Crystallization
- Nanomaterials
- Nanocomposites
- Endothelial Dysfunction
- Liquid Chromatography
- Synthesis
- Pharmaceutical Analysis
- Green Analytical Chemistry
- Validation
- Chiral Separation
- Catalysis
- Biological Evaluation
- Inflammation
- Asymmetric Synthesis
- Drug Discovery
- Oxidative Stress
- Carcinogenicity
- Chemoselective
- Green Chemistry
- Nitric Oxide
- Bioinspired Materials
- Medicinal Chemistry
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 29 words, with their numbers
- Green Analytical Chemistry3▲ 117×2 topics
- Pharmaceutical Analysis3▲ 334×1 topic
- Validation3▲ 105×1 topic
- Synthesis3▲ 15×9 topics
- Chiral Separation2▲ 66×1 topic
- Liquid Chromatography2▲ 55×1 topic
- Catalysis2▲ 7.5×5 topics
- Endothelial Dysfunction2▲ 20×2 topics
- Biological Evaluation2▲ 44×5 topics
- Nanocomposites2▲ 6.7×2 topics
- Inflammation2▲ 2.1×2 topics
- Nanomaterials2▲ 6.0×4 topics
- Asymmetric Synthesis1▲ 31×3 topics
- Crystallization1▲ 77×2 topics
- Drug Discovery1▲ 12×4 topics
- Heterocyclic Compounds1▲ 26×4 topics
- Oxidative Stress1▲ 2.4×2 topics
- Biomedical Applications1▲ 3.8×2 topics
- Carcinogenicity1▲ 38×3 topics
- Cardiovascular Diseases1▲ 32×1 topic
- Chemoselective1▲ 28×3 topics
- Genotoxicity1▲ 79×3 topics
- Green Chemistry1▲ 14×3 topics
- Natural Products1▲ 22×2 topics
- Nitric Oxide1▲ 71×1 topic
- Reactive Oxygen Species1▲ 8.1×2 topics
- Bioinspired Materials1▲ 45×1 topic
- Biomineralization1▲ 39×1 topic
- Medicinal Chemistry1▲ 9.3×5 topics
Which research topics does Megafine Pharma (India) publish most on?
By volume in 2022–2025: Analytical Chemistry and Chromatography, Adsorption, diffusion, and thermodynamic properties of materials, Nitric Oxide and Endothelin Effects and Water Treatment and Disinfection.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Analytical Chemistry and Chromatography Spectroscopy 0 works
- 2 Adsorption, diffusion, and thermodynamic properties of materials Spectroscopy 0 works
- 3 Nitric Oxide and Endothelin Effects Physiology 0 works
- 4 Water Treatment and Disinfection Health, Toxicology and Mutagenesis 0 works
- 5 Pharmaceutical Quality and Counterfeiting Public Health, Environmental and Occupational Health 0 works
- 6 Chemical Thermodynamics and Molecular Structure Organic Chemistry 0 works
- 7 Chemical Reactions and Isotopes Pharmaceutical Science 0 works
- 8 Metal complexes synthesis and properties Oncology 0 works
- 9 Molecular spectroscopy and chirality Spectroscopy 0 works
- 10 Free Radicals and Antioxidants Organic Chemistry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Megafine Pharma (India)'s research output changed?
Output in 2018–2022 was 56% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mumbai
- Indian Institute of Technology Bombay
- Bhabha Atomic Research Centre
- Tata Institute of Fundamental Research
- University of Mumbai
- Institute of Chemical Technology
- Homi Bhabha National Institute
- Tata Memorial Hospital
- Narsee Monjee Institute of Management Studies
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.